Trials in Combination Therapy for CLL - Phase 2 Trial results with Obinutuzumab, Ibrutunib, & Venetoclax - 100459

Spotlight
Video

Trials in Combination Therapy for CLL - Phase 2 Trial results with Obinutuzumab, Ibrutunib, & Venetoclax

moasc has 248 videos Subscribe Here

Loading........
Description: Miguel Risco, MD, from UC-Irvine Department of Hematology and Oncology joins us at MOASC’s Spotlight On® Hematology in Huntington Beach to discuss the trials in combination therapy for Chronic Lymphocytic Leukemia and the phase 2 trial results with Obinutuzumab, Ibrutunib, & Venetoclax in conjunction.
Shared By : moasc
Posted on : 02/01/18
Added : 18 days ago



Recommended

Nothing found.

More From moasc

Nothing found.